Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Lipid Luminations

Genetic Testing to Improve Risk Assessment and Guide Therapies in Patients Facing Heart Disease

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    Dr. Christie Ballantyne discusses with host Dr. Alan Brown the use of genetic testing in various phases of disease onset in patients facing heart disease. They talk about how clinicians can utilize the current technologies, what the costs are and the benefits. How does learning more about the genetic mutation behind familial hypercholesterolemia affect treatment? Dr. Ballantyne and Dr. Brown also discuss what new genetic testing techniques are on the horizon.

    Brought to you by:

    NLA logo

Recommended
Details
Presenters
Comments
  • Overview

    Dr. Christie Ballantyne discusses with host Dr. Alan Brown the use of genetic testing in various phases of disease onset in patients facing heart disease. They talk about how clinicians can utilize the current technologies, what the costs are and the benefits. How does learning more about the genetic mutation behind familial hypercholesterolemia affect treatment? Dr. Ballantyne and Dr. Brown also discuss what new genetic testing techniques are on the horizon.

    Brought to you by:

    NLA logo

Schedule2 Dec 2024